"For 2026, we are maintaining our cash operating expense guidance of less than $390 million." (CFO & President of Recursion UK Taylor). "We expect multiple clinical readouts over the next 12 to 18 ...

Anthropic wants developers to build faster with Claude. It also wants policymakers to understand that AI may soon be too ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Good morning, everyone, and thank you for joining us. Since stepping into this role, I've been focused on a singular question: how do we harness the full power of AI to consistently and with urgency ...

If you've ever taken an introductory astronomy class, you've probably seen the Hertzsprung-Russell (HR) diagram. This graph ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

An interview with Google DeepMind product VP Tulsee Doshi. Google announced a slew of new and updated AI products and ...

At Team '26, the company announces a powerhouse of new AI capabilities built for every corner of modern work Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and ...

Traditional SaaS sold seats. Agentic AI sells work completed, time saved, throughput increased, revenue generated. The ...

Earnings call Recursion Pharmaceuticals delivered strong operational progress with a 30% YoY reduction in operating expenses and an extended cash runway into early 2028. Clinical momentum was ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate ...

Towards the end of 2025, AI systems suddenly became capable of writing entire computer programs on their own, a moment that ...